Dr. Ogasawara is a registered and qualified patent attorney (benrishi). He has been involved with various patent matters and is well versed in international and domestic patent filing and prosecution. He is specialized in Genetic engineering, Pharmaceuticals, Food, Microbiology, Regenerative medicine, Distillation/Extraction, Batteries, Optical devices.

Mr. Okamoto is a registered and qualified patent attorney (benrishi). He has been involved with various patent matters and is well versed in international and domestic patent filing and prosecution. He is specialized in Mechanical devices, Life Science and Food Engineering.

Mr. Nakamachi is a fully bilingual and bicultural attorney and possesses over 30 years of solid experience as a practicing lawyer in the United States and Japan. He has the rare distinction among Japanese lawyers of having served as a partner at top-tier law firms in both of the two countries. He has special expertise in intellectual property/technology transactions for technology-driven clients, ranging from young start-ups to fully-matured global enterprises. Aki represents clients operating in a wide range of industries, including software, Internet, e-commerce, computer gaming, computer equipment, telecommunications, automobile, semiconductor, pharmaceuticals, biotech and medical devices. With over 10 years of work experience at first-tier national U.S. law firms across the United States, Aki has acquired exceptionally deep and practical knowledge of not only the laws but also the "business culture" of both the United States and Japan, and utilizes his expertise to assist clients in achieving successful outcomes in cross-border commercial transactions and dispute resolution matters.

Junichi Kondo is a partner at Anderson Mori & Tomotsune and is engaged principally in the fields of general corporate matters with an emphasis on M&A, joint venture and other corporate transactions including M&A-related financing. His scope of experience also includes healthcare matters including pharmaceutical regulations and software licensing.

Shinji Kusakabe specializes in advising on legal issues in manufacturing, such as commercial transactions and product liabilities. Mr. Kusakabe has a wealth of practical experience in litigation and arbitration, both international and domestic. Mr. Kusakabe's particular specialties lie in providing targeted advice to clients on corporate matters, taking into consideration potential future disputes, and in resolving current disputes in light of actual business practices and circumstances. Cases which Mr. Kusakabe has recently handled include lawsuits related to termination of commercial relationships, illegal transactions conducted by employees, product liability, bid-rigging conspiracies and inventions by employees. Mr. Kusakabe is also actively engaged in international arbitration, including matters arbitrated outside Japan. In addition to his professional experience at Anderson Mori & Tomotsune, Mr. Kusakabe's prior experience includes working as a Foreign Associate at Kelley Drye & Warren's New York office (September 1999 to August 2000) and a full-time secondment to Swiss Bank Corporation's (now UBS AG) Tokyo Legal & Compliance department (February to July 1998). Mr. Kusakabe also served as: Executive Director, the Headquarters for Comprehensive Promotion of Civil Justice Reform of the Japan Federation of Bar Associations (from June 2026); Member of the Advisory Committee for the Establishment of Civil Rules of the Supreme Court (from August 2025); Special Assistant to the President of the Japan Federation of Bar Associations (from April 2025 to September 2025); President of the Daini Tokyo Bar Association (from April 2024 to March 2025); Vice President of the Japan Federation of Bar Associations (from April 2024 to March 2025); Expert Member of the Nuclear Damage Compensation Dispute Review Board (from June 2022 to June 2023); Member of the Code of Civil Procedure (for Introduction of IT) Subcommittee of the Legislative Council of the Ministry of Justice (from June 2020 to February 2022); Governor of the Japan Federation of Bar Associations (from April 2020 to March 2021; Executive Governor from June 2020 to March 2021); Chair of the Committee on Civil Procedure of the Japan Federation of Bar Associations (from June 2019 to May 2021); Examiner for the National Bar Examination and the National Preliminary Bar Examination (in Charge of the Code of Civil Procedure) (from November 2018 to November 2021); Vice President of the Daini Tokyo Bar Association (from April 2017 to March 2018); and Practicing-Attorney-Professor for Civil Advocacy at the Legal Training and Research Institute of the Supreme Court of Japan (from April 2010 to March 2013) (for details of this position, please visit http://www.courts.go.jp/english/institute_01/institute/index.html#Intro ).

Ryo Okochi has expertise in cross border mergers and acquisitions, joint venture, and corporate restructuring. His practice focuses on transactions related to emerging countries such as India, Sri Lanka, Bangladesh, ASEAN countries and other African countries.

Masayuki holds a master's degree in science, and has been engaged in a number of patent infringement lawsuits and other IP related matters since he became a lawyer. His main focus is on the pharmaceutical industry, in patent infringement actions as well as licensing negotiations, joint development projects, and technology transfer projects. He also has expertise and experience in other forms of intellectual property, including trademarks, copyrights, and trade secrets. In addition, with his experience in the U.S. (both in law school and at a law firm focusing on patent matters), he also provides advice to clients involved in patent lawsuits in the U.S.

Yuta Oishi has engaged in a wide range of IP related matters, including patent, copyright, and trademark infringement lawsuits, licensing negotiations, as well as technology related projects. Moreover, He specializes in data related business and has provided an extensive variety of advice regarding data protection, cyber security, and trade secrets. In addition, he possesses a vast array of experience in assisting with transactional, regulatory, and other legal matters in fields that pertain to and expand across the pharmaceutical, healthcare (including digital healthcare), IT, and entertainment industries.